Schedule 13G ownership disclosure

Cerulean Pharma Inc.

Security class unavailable · CUSIP: 15708Q105

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,601,387
Percent of class
9.4800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000913849-17-000035
Form type
SC 13G/A
Filer
CVF, LLC
CIK
CIK 1112278
Filed
Feb 10, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub